Abstract:Sepsis is a systemic inflammatory response to infection. A common end-feature, these patients regularly suffer from is the so-called multiple organ dysfunction syndrome, an often fatal consequence of organ hypoperfusion, coagulopathy, immune dysregulation, and mitochondrial dysfunction. Microvascular dysfunction critically contributes to the morbidity and mortality of this disease. The angiopoietin (Angpt)/Tie2 system consists of the transmembrane endothelial tyrosine kinase Tie2 and its circulating ligands (A… Show more
“…In the context of the developing blood vessels, this may alter the expression of pro-angiogenic signaling molecules such as VEGF as well as molecules that maintain blood vessel integrity (e.g., angiopoeitin-1/2). 52 The in vivo expression of SP-A in the mouse retina after intravitreal injection of TLR-2 and TLR-4 ligands demonstrates that inflammatory pathways induced by common bacterial pathogens (e.g., LPS-mediated TLR-4 activation) led to an increase in retinal SP-A levels, Although our data are from adult mice, several studies have shown an increased risk of ROP in the face of maternal chorioamnionitis with postnatal infections and sepsis. 21,53 Our in vivo studies demonstrated that SP-A expression was more pronounced for LPS-mediated TLR-4 activation, although Pam3Cys-mediated TLR-2 activation was found to occur earlier (12 hours vs. 6 hours).…”
Section: Sp-a Up-regulation Is Mediated By Tlrs and Nfjb Pathwaymentioning
PURPOSE. Surfactant protein A (SP-A) up-regulates cytokine expression in lung disease of prematurity. Here we present data that for the first time characterizes SP-A expression and localization in the mouse retina and its impact on neovascularization (NV) in the mouse.
“…In the context of the developing blood vessels, this may alter the expression of pro-angiogenic signaling molecules such as VEGF as well as molecules that maintain blood vessel integrity (e.g., angiopoeitin-1/2). 52 The in vivo expression of SP-A in the mouse retina after intravitreal injection of TLR-2 and TLR-4 ligands demonstrates that inflammatory pathways induced by common bacterial pathogens (e.g., LPS-mediated TLR-4 activation) led to an increase in retinal SP-A levels, Although our data are from adult mice, several studies have shown an increased risk of ROP in the face of maternal chorioamnionitis with postnatal infections and sepsis. 21,53 Our in vivo studies demonstrated that SP-A expression was more pronounced for LPS-mediated TLR-4 activation, although Pam3Cys-mediated TLR-2 activation was found to occur earlier (12 hours vs. 6 hours).…”
Section: Sp-a Up-regulation Is Mediated By Tlrs and Nfjb Pathwaymentioning
PURPOSE. Surfactant protein A (SP-A) up-regulates cytokine expression in lung disease of prematurity. Here we present data that for the first time characterizes SP-A expression and localization in the mouse retina and its impact on neovascularization (NV) in the mouse.
“…Although some studies suggest a protective role of Angpt-2 in the context of infection, the majority of the literature supports the concept that Angpt-2 is deleterious in sepsis (reviewed in 55 ). Recently, Western analysis of lung homogenates from septic mice has shown that Angpt-2 siRNA-knockdown restores Tie2 phosphorylation, providing in vivo evidence that the induction of Angpt-2 in sepsis leads to Tie2 deactivation and that Angpt-2 worsens outcomes in sepsis.…”
“…Ang-1 and -2 are important regulators of angiogenesis, inflammation and vascular permeability [78,79]. Binding of constitutively expressed Ang-1 to Tie2 induces endothelial quiescence, integrity and barrier stabilisation.…”
Dysregulation of the innate immune system drives lung injury and its systemic sequelae due to breakdown of vascular barrier function, harmful hyperinflammation and microcirculatory failure, which contribute to the unfavourable outcome of patients with severe pneumonia. A variety of promising therapeutic targets have been identified and numerous innovative therapeutic approaches demonstrated to improve lung injury in experimental preclinical studies. However, at present specific preventive or curative strategies for the treatment of lung failure in pneumonia in addition to antibiotics are still missing. The aim of this mini-review is to give a short overview of some, but not all, adjuvant therapeutic strategies for pneumonia and its most important complications, sepsis and acute respiratory distress syndrome, and briefly discuss future perspectives. @ERSpublications A review of preclinical and clinical research on adjuvant therapies for pneumonia
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.